Lipid Effects of Avandia

The lipid effects of Avandia can be both positive and negative. Although Avandia was shown to increase HDL cholesterol ("good" cholesterol) by 11.4 to 14.2 percent in people taking the medicine during clinical studies, it also increased LDL cholesterol ("bad" cholesterol) by 14.1 to 18.6 percent.

Does Avandia Have an Effect on Lipid Levels?

Avandia® (rosiglitazone maleate) is a prescription medication used to treat type 2 diabetes. It is a member of the thiazolidinedione group of diabetes medications. Although Avandia has many beneficial effects on blood sugar, it may also have effects on good cholesterol (HDL), bad cholesterol (LDL), and free fatty acids.
 
In September 2010, the U.S. Food and Drug Administration (FDA) announced that it would be severely restricting the use of Avandia, due to the risk of "cardiovascular events" such as heart attacks and strokes. Only individuals who cannot control their diabetes on other medications (or those who are already taking the medication and doing well) will be able to take Avandia.
 

Cholesterol Effects of Avandia: What Does the Research Show?

In studies, Avandia increased LDL cholesterol ("bad" cholesterol) by 14.1 to 18.6 percent. However, it also increased HDL cholesterol ("good" cholesterol) by 11.4 to 14.2 percent. While these changes cause an increase in total cholesterol, they usually keep the ratio of total cholesterol to HDL the same. In other words, Avandia increases both good and bad cholesterol by about the same amount.
 
(Click Cholesterol Guidelines for more information about cholesterol levels.)
 

Free Fatty Acids and Avandia

In these same studies, Avandia was shown to decrease free fatty acids by as much as 14.
 7 percent. Free fatty acids are related to triglycerides, but are not the same as triglycerides. In fact, triglyceride levels did not change in these studies. Free fatty acids are often higher in people who are obese or who have diabetes, and may be linked to insulin resistance or other diabetes complications.
 
Lipid Effects of Avandia Article Continues on Next Page >
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation